Johnson & Johnson Note Agreements

35 Contracts & Agreements
Recent Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
Johnson & Johnson 3.700% Note Due 2055 (Indenture Debt Security Certificate)
Note Agreements
Johnson & Johnson
Pharmaceuticals
NJ
2025
Johnson & Johnson 3.600% Note Due 2045 Issued Under Indenture to The Bank of New York Mellon Trust Company
Note Agreements
Johnson & Johnson
Pharmaceuticals
NJ
2025
Johnson & Johnson 3.350% Note Due 2037 (Indenture Debt Security Certificate)
Note Agreements
Johnson & Johnson
Pharmaceuticals
NJ
2025
Johnson & Johnson 3.050% Note Due 2033 Issued to The Bank of New York Depository (Nominees) Limited
Note Agreements
Johnson & Johnson
Pharmaceuticals
NJ
2025
Johnson & Johnson 2.700% Note Due 2029 Issued to The Bank of New York Depository (Nominees) Limited
Note Agreements
Johnson & Johnson
Pharmaceuticals
NJ
2025
Johnson & Johnson Company Order for Issuance of Euro-Denominated Notes (2029–2055)
Note Agreements
Johnson & Johnson
Pharmaceuticals
2025
Johnson & Johnson 5.000% Note Due 2035 (Indenture Debt Security Certificate)
Note Agreements
Johnson & Johnson
Pharmaceuticals
NJ
2025
Johnson & Johnson 4.850% Note Due 2032 (Indenture Debt Security)
Note Agreements
Johnson & Johnson
Pharmaceuticals
NJ
2025
Johnson & Johnson 4.700% Note Due 2030 (Global Note)
Note Agreements
Johnson & Johnson
Pharmaceuticals
NJ
2025
Johnson & Johnson 4.550% Note Due 2028 (Indenture Debt Security Certificate)
Note Agreements
Johnson & Johnson
Pharmaceuticals
NJ
2025
Johnson & Johnson 4.500% Note Due 2027 (Global Note)
Note Agreements
Johnson & Johnson
Pharmaceuticals
NJ
2025
Johnson & Johnson 3.550% Note Due 2044 (Indenture Debt Security)
Note Agreements
Johnson & Johnson
Pharmaceuticals
NJ
2024
Johnson & Johnson 3.350% Note Due 2036 (Indenture Debt Security)
Note Agreements
Johnson & Johnson
Pharmaceuticals
NJ
2024
Johnson & Johnson 3.200% Note Due 2032 (Euro) – The Bank of New York Depository (Nominees) Limited
Note Agreements
Johnson & Johnson
Pharmaceuticals
NJ
2024
Johnson & Johnson Order for Issuance of Euro-Denominated Notes Due 2032, 2036, and 2044
Note Agreements
Johnson & Johnson
Pharmaceuticals
2024
Johnson & Johnson 5.250% Note Due 2054 (Indenture Debt Security Certificate)
Note Agreements
Johnson & Johnson
Pharmaceuticals
NJ
2024
Johnson & Johnson 4.950% Note Due 2034 (Indenture Debt Security)
Note Agreements
Johnson & Johnson
Pharmaceuticals
NJ
2024
Johnson & Johnson 4.900% Note Due 2031 (Indenture Debt Security Certificate)
Note Agreements
Johnson & Johnson
Pharmaceuticals
NJ
2024
Johnson & Johnson 4.800% Note Due 2029 (Indenture Debt Security Certificate)
Note Agreements
Johnson & Johnson
Pharmaceuticals
NJ
2024
Johnson & Johnson Order for Issuance of Series Notes under Indenture (May 2024)
Note Agreements
Johnson & Johnson
Pharmaceuticals
2024
Johnson & Johnson Company Order for Issuance of Series Notes (2025–2060)
Note Agreements
Johnson & Johnson
Pharmaceuticals
2020
Johnson & Johnson Order for Issuance of Series Notes under Indenture (November 2017)
Note Agreements
Johnson & Johnson
Pharmaceuticals
2017
Johnson & Johnson Company Order for Issuance of Notes under Indenture (February 2017)
Note Agreements
Johnson & Johnson
Pharmaceuticals
2017
Johnson & Johnson 1.650% Note Due 2035 Issued to The Bank of New York Depository (Nominees) Limited
Note Agreements
Johnson & Johnson
Pharmaceuticals
NJ
2016
Johnson & Johnson 1.150% Note Due 2028 Issued to The Bank of New York Depository (Nominees) Limited
Note Agreements
Johnson & Johnson
Pharmaceuticals
NJ
2016
Johnson & Johnson 0.650% Note Due 2024 Issued to The Bank of New York Depository (Nominees) Limited
Note Agreements
Johnson & Johnson
Pharmaceuticals
NJ
2016
Johnson & Johnson 0.250% Note Due 2022 (Indenture Debt Security)
Note Agreements
Johnson & Johnson
Pharmaceuticals
NJ
2016
Johnson & Johnson Company Order for Issuance of Euro-Denominated Notes (2016)
Note Agreements
Johnson & Johnson
Pharmaceuticals
2016
Johnson & Johnson Company Order for Issuance of Notes under 1987 Indenture
Note Agreements
Johnson & Johnson
Pharmaceuticals
2016
Johnson & Johnson Company Order for Issuance of Notes under 1987 Indenture (2014)
Note Agreements
Johnson & Johnson
Pharmaceuticals
2014
Johnson & Johnson Order for Issuance of Notes under 1987 Indenture (2013)
Note Agreements
Johnson & Johnson
Pharmaceuticals
2013
Johnson & Johnson Company Order Establishing Terms of 2.95% and 4.50% Notes Due 2020 and 2040
Note Agreements
Johnson & Johnson
Pharmaceuticals
2010
Johnson & Johnson Floating Rate Note Due 20XX (Form of Note)
Note Agreements
Johnson & Johnson
Pharmaceuticals
NJ
2013
Johnson & Johnson Floating Rate Note Due 20[•] (Form of Note)
Note Agreements
Johnson & Johnson
Pharmaceuticals
NJ
2011
Johnson & Johnson Company Order for Issuance of Notes (May 2011)
Note Agreements
Johnson & Johnson
Pharmaceuticals
2011